Next Vision (NXSN) AI Stock Analysis

• Market Cap: 22.50B
• Dividend Yield: 0.77%
• Average Volume (3M): 322.29K
• Price to Earnings (P/E): 63.0
• Beta (1Y): 1.13
• Revenue Growth: 39.62%
• EPS Growth: 40.53%
• Country: IL
• Employees: 88
• Sector: Technology
• Sector Strength: 88
• Industry: Security & Protection Services
• EPS (TTM): 103.95
• Shares Outstanding: 91,076,050
• 10 Day Avg. Volume: 498,567
• 30 Day Avg. Volume: 322,285
• PEG Ratio: 0.16
• Price to Book (P/B): 10.16
• Price to Sales (P/S): 12.17
• P/FCF Ratio: 21.19
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: 17,900.00
• Price Target Upside: 21.77% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 71 Outperform
• Price Target: 27,294.00 ▲(85.67% Upside)

Next Vision's strong financial performance is the primary driver of its stock score, supported by robust revenue growth and profitability. However, technical indicators suggest the stock may be overbought, and high valuation metrics could limit further upside. The absence of earnings call and corporate events data means these factors do not influence the score.

Positive Factors

Revenue Growth

Sustained near-100% TTM revenue growth indicates strong product-market fit and rapid adoption across healthcare and industrial customers. Over 2–6 months this supports expanding market share, scale advantages, and the ability to fund R&D and platform development without relying solely on external capital.

High Profitability Margins

Exceptionally high gross and net margins show durable pricing power and efficient cost structure in core imaging and AR offerings. These margins provide long-term flexibility to invest in product development, absorb competitive pressure, and sustain cash generation as the company scales its recurring software and services.

Low Leverage & Strong ROE

Minimal leverage and a very high ROE reflect conservative financing and efficient capital use, reducing insolvency risk while maximizing shareholder returns. Over months, low debt preserves strategic optionality for M&A or capex, and strong ROE indicates effective execution on deployed equity capital.

Negative Factors

Cash Flow Growth Lag

Free cash flow rising far slower than revenue suggests working capital needs or reinvestment are consuming cash. Persisting over months this could pressure margins, increase reliance on financing for growth, or limit ability to self-fund capex and R&D despite strong top-line expansion.

Small Workforce

A lean headcount versus rapid revenue expansion can strain delivery, support, and R&D capacity. Over the next several months this structural constraint may increase operational risk, slow product rollouts, and require rapid hiring investments that temporarily raise costs and execution complexity.

Incomplete Balance Sheet Disclosure

Missing equity ratio and limited asset financing detail reduce transparency on capital structure and leverage dynamics. Persisting disclosure gaps hinder thorough risk assessment, complicate forecasting of solvency under stress, and may mask structural funding or liquidity needs over time.

Next Vision Business Overview & Revenue Model

Company Description

Next Vision (NXSN) is a forward-thinking technology company specializing in advanced optical imaging solutions and augmented reality (AR) applications. Operating primarily in the healthcare and industrial sectors, NXSN develops cutting-edge products that enhance visual capabilities for diagnostics, maintenance, and training purposes. The company's core offerings include high-resolution imaging systems, AR software platforms, and integrated hardware solutions designed to improve efficiency and accuracy in various professional environments.

How the Company Makes Money

Next Vision generates revenue through a diversified model encompassing direct product sales, subscription services, and strategic partnerships. The primary revenue stream comes from the sale of imaging systems and AR devices to healthcare providers and industrial clients, enabling them to leverage advanced technology for improved operational outcomes. Additionally, NXSN offers subscription-based access to its proprietary software platforms, providing ongoing support and updates to clients. The company has also established significant partnerships with key industry players, which contribute to joint ventures and collaborative projects, further enhancing its market reach and financial stability.

Next Vision Financial Statement Overview

Summary

Next Vision exhibits outstanding financial performance with significant revenue growth of 97.71% TTM, high profitability margins, and strong cash flow generation. The low debt-to-equity ratio enhances financial stability. However, cash flow growth lags behind revenue growth, which may require attention.

Income Statement

Next Vision's income statement is exceptionally strong, with a remarkable revenue growth rate of 97.71% TTM, indicating robust expansion. The company maintains high profitability with a gross profit margin of 72.68% and a net profit margin of 60.02% TTM, showcasing efficient cost management and strong pricing power. EBIT and EBITDA margins are also impressive at 68.01% and 69.31% TTM, respectively, reflecting operational efficiency.

Balance Sheet

The balance sheet of Next Vision is solid, with a low debt-to-equity ratio of 0.02 TTM, indicating minimal leverage and financial risk. The return on equity is exceptionally high at 59.25% TTM, demonstrating effective use of shareholders' equity to generate profits. However, the equity ratio is not provided, which limits a full assessment of asset financing.

Cash Flow

Next Vision's cash flow statement shows positive trends, with a free cash flow growth rate of 11.54% TTM, indicating healthy cash generation. The operating cash flow to net income ratio of 2.12 TTM suggests strong cash conversion, and the free cash flow to net income ratio of 0.94 TTM indicates efficient cash utilization. However, the growth rate, while positive, is not as high as the revenue growth, suggesting potential reinvestment or operational cash flow challenges.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	262.75M	114.93M	51.94M	26.05M	15.03M	7.86M
Gross Profit	108.19M	82.89M	35.62M	17.26M	9.41M	3.96M
EBITDA	178.59M	78.09M	28.82M	13.44M	6.85M	2.84M
Net Income	89.91M	66.40M	27.57M	11.15M	5.74M	2.15M
Balance Sheet
Total Assets	610.00M	159.16M	96.49M	64.27M	51.37M	6.92M
Cash, Cash Equivalents and Short-Term Investments	1.75B	122.61M	68.63M	53.90M	42.84M	2.58M
Total Debt	11.34M	496.00K	671.00K	257.00K	403.00K	352.00K
Total Liabilities	28.00M	21.46M	16.56M	7.59M	3.56M	1.74M
Stockholders Equity	1.92B	137.69M	79.93M	56.68M	47.81M	5.18M
Cash Flow
Free Cash Flow	54.04M	66.01M	20.35M	14.32M	3.67M	549.00K
Operating Cash Flow	103.01M	68.41M	21.80M	15.60M	4.47M	905.00K
Investing Cash Flow	-1.59B	-50.10M	7.27M	1.94M	-12.85M	-356.00K
Financing Cash Flow	1.37B	-11.74M	-5.79M	-2.98M	36.69M	-559.00K

Next Vision Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 14700.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:NXSN, the sentiment is Positive. The current price of 14700 is below the 20-day moving average (MA) of 22203.50, below the 50-day MA of 17952.00, and above the 200-day MA of 13568.41, indicating a bullish trend. The MACD of 2145.81 indicates Negative momentum. The RSI at 69.01 is Neutral, neither overbought nor oversold. The STOCH value of 73.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IL:NXSN.

Next Vision Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HLAN	76 Outperform	6.11B	23.20	22.56%	1.88%	7.39%	10.64%
ONE	76 Outperform	7.15B	26.11	―	2.55%	14.11%	25.79%
FORTY	73 Outperform	8.20B	31.96	―	2.68%	1.94%	-8.81%
NXSN	71 Outperform	22.50B	62.96	―	0.77%	39.62%	40.53%
MTRX	66 Neutral	9.49B	32.02	―	2.41%	8.82%	14.25%
MLTM	62 Neutral	3.08B	30.32	―	―	11.90%	13.57%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%